Inhibition of Scavenger Receptor Class B Type 1 (SR-B1) Expression and Activity as a Potential Novel Target to Disrupt Cholesterol Availability in Castration-Resistant Prostate Cancer.

Pandey, Mitali; Cuddihy, Grace; Gordon, Jacob A; Cox, Michael E; Wasan, Kishor M

Pandey, Mitali; Cuddihy, Grace; Gordon, Jacob A; Cox, Michael E; Wasan, Kishor M.

Afiliación

Pandey M; Department of Urological Sciences, Faculty of Medicine, University of British Columbia, Vancouver Prostate Centre, Vancouver, BC V6T 1Z3, Canada.
Cuddihy G; College of Pharmacy and Nutrition, University of Saskatchewan, 104 Clinic Place, Saskatoon, SK S7N 2Z4, Canada.
Gordon JA; Oncology Bioscience, Oncology R&D, AstraZeneca, Boston, MA 02451, USA.
Cox ME; Department of Urological Sciences, Faculty of Medicine, University of British Columbia, Vancouver Prostate Centre, Vancouver, BC V6T 1Z3, Canada.
Wasan KM; Department of Urological Sciences, Faculty of Medicine, University of British Columbia, Vancouver Prostate Centre, Vancouver, BC V6T 1Z3, Canada.

Pharmaceutics ; 13(9)2021 Sep 18.

Article en En | MEDLINE | ID: mdl-34575583

Palabras clave

castration-resistant prostate cancer; cholesterol uptake; patient survival; prostate cancer; scavenger receptor Class B type I high-density lipoproteins

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Pharmaceutics Año: 2021 Tipo del documento: Article País de afiliación: Canadá

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Pharmaceutics Año: 2021 Tipo del documento: Article País de afiliación: Canadá